LifeCord Inc.
Cryopreserved cord blood fractions alternative source of mesenchymal stem cells
Published in Cardiovascular Device Liability Week, September 26th, 2004
"Umbilical cord blood (UCB) is well known to be a rich source of hematopoietic stem cells with practical and ethical advantages, but the presence of mesenchymal stem cells (MSCs) in UCB has been disputed and it remains to be validated.
"In this study, we examined the ability of cryopreserved UCB harvests to produce cells with characteristics of MSCs," scientists in South Korea report.
"We were able to obtain homogeneous plastic adherent cells from the mononuclear cell fractions of cryopreserved UCB using our culture conditions. These adherent...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Cardiac Science, Inc.
$3.7M AED orders placed from Nihon Kohden in Japan - CHI, Creteil
Airway dysfunction syndrome caused by fire extinguishers - Medical Surgical Center of Europe, Le Port Marly
A transradial approach for diagnostic angiography is evaluated - Transplant Medicine
Woman says U.S. government blocking transplant - University of Texas
Organized healthcare delivery in Texas prison system improves health outcomes - Worcester Polytechnic Institute
3-D fluid-structure interactions models may be able to predict plaque rupture - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
